Abortion bans turn miscarriage care into a gamble

abortion bans – A Texas trigger ban that makes abortion after fertilization a felony has had wider consequences than the law’s drafters predicted, pushing doctors toward delayed or less common miscarriage treatments. A new JAMA study finds shifts away from medication care and

In 2022. as soon as Texas’s trigger ban went into effect after the Supreme Court’s Dobbs decision overturned Roe v. Wade, the rules for pregnancy care changed overnight. For doctors. performing an abortion after the moment of fertilization became a punishable felony. with penalties that could include up to life in prison. Exceptions existed on paper—“a life-threatening physical condition aggravated by. caused by. or arising from a pregnancy”—but how and when those exceptions would be honored in real life stayed unclear.

For Kyleigh Thurman, the uncertainty translated into repeated trips to the emergency room. In 2023, the 34-year-old began bleeding heavily without knowing she was pregnant. Her doctor encouraged a pregnancy test. It came back positive. She continued to experience cramping. dizziness. and more bleeding. eventually ending up at the ER a total of six times for treatment and diagnosis.

Thurman says doctors first sent her home, telling her she was simply having a miscarriage. The picture changed later when tests confirmed an ectopic pregnancy.

“I was advocating so hard for myself,” Thurman told Salon in a phone interview. “I was going to the hospital, I was vocal, I was saying, here’s my OB, here’s my records, she’s saying explicitly, this is ectopic, and none of the ER doctors would respond.”

What followed shows how thin the margins can be when abortion restrictions collide with emergency medicine. Doctors gave Thurman a methotrexate injection only after her OB-GYN went to the hospital and spoke to staff in person on her fourth emergency-room visit. Several days after the injection, she developed signs of an ectopic pregnancy rupture, leading to emergency surgery. Her right fallopian tube was removed.

Her experience is part of a broader shift that public health experts warned about after Dobbs. When restrictive abortion laws spread. they argued they would endanger not only people with unintended pregnancies but also those miscarrying or facing emergencies like ectopic pregnancies—“anyone with a uterus. ” as the concern was framed.

That warning now has fresh, population-level evidence.

A study published in JAMA this month found that nearly four years after Dobbs. abortion bans are affecting standard. evidence-based care for miscarriages. The study specifically found a shift away from medication management—using the abortion drugs mifepristone and misoprostol together—toward “expectant management. ” in which a person waits for a miscarriage to happen on its own without intervention. which the research describes as usually the only option in abortion ban states.

The researchers analyzed data between 2018 and 2024 covering more than 123,000 people who experienced a miscarriage before 10 weeks of pregnancy. In that dataset, abortion bans were associated with a 2.8% increase in expectant management and a 2.2% decrease in medication management. Among those who did receive medication. abortion ban states saw a 13.8% increase in misoprostol-only regimens compared with combining misoprostol with mifepristone.

The reason, as clinicians describe it, is not just clinical preference. It’s the shadow of legal risk—because even when laws include so-called exceptions, discretion is often left to physicians, and penalties can be severe if the law is interpreted as having been violated.

Maria Rodriguez. director of the OHSU Center for Women’s Health and co-author of the study. said in a statement: “Patients are having to wait longer to receive treatment. and when they arrive. they have fewer choices. These are very real and dangerous clinical implications for the hundreds of thousands of women experiencing miscarriages annually.”.

Rodriguez. in an interview with Salon. said she was surprised the effect wasn’t greater but pointed out that the population studied had private insurance—people who typically have more resources than those who are uninsured or on Medicaid. She also said multiple factors could be contributing to the observed impact.

“There could be fewer doctors available to provide care given the research showing doctors and other clinicians are leaving states with abortion bans,” Rodriguez said. “Fear of violating abortion bans may also delay care, but so could increased restrictions on mifepristone.”

The study’s findings land in a context where miscarriage treatment is usually described in options, not in one default. The American College of Obstetricians and Gynecologists explains that there are three main ways to treat a miscarriage. with the goal of removing any tissue left from the pregnancy in the uterus. Two nonsurgical treatments are expectant management and medication management. The third option is a surgical procedure called dilation and curettage, also known as D&C. Medication management—such as mifepristone plus misoprostol and a D&C—also overlaps with how clinicians terminate unwanted pregnancies.

In many cases, ACOG advises patients experiencing a miscarriage to choose the treatment they prefer.

But when a law makes part of that medical decision a felony, choice can shrink fast—sometimes until care is delayed or limited.

Dr. Rachel Jensen. an OB-GYN and specialist in complex family planning. told Salon that the study adds to a growing body of evidence suggesting that Dobbs and subsequent state abortion laws have had “significant impacts on care. beyond access to induced abortion.” Jensen said the uncertainty and fear of legal repercussions can cause delays or limit evidence-based options for people experiencing pregnancy loss. She also called it “particularly” concerning that abortion ban states showed a decline in the use of mifepristone. arguing that it reflects access disparities between restricted and non-restricted states—disparities that could widen existing gaps in maternal mortality and morbidity.

Jensen added that withholding or reducing options increases risk for complications such as infection or hemorrhage. Those complications, she said, could lead to more invasive procedures, lengthy hospital stays, or even death.

Rodriguez said her team is now looking at outcomes of treatment for ectopic pregnancies.

David Hackney. a maternal-fetal medicine specialist who was not involved in the study or Thurman’s case. said he wasn’t surprised by the data and the stories. “Individual stories of altered and suboptimal miscarriage management emerged quickly in the days following Dobbs. including several overtly tragic examples. ” Hackney said. “Abortion is never siloed. but rather intersects broadly with obstetrics and medicine itself. such that legislative efforts to restrict abortion ripple inevitably through other aspects of patient care.”.

The sequence—from legal change to clinic uncertainty to delayed treatment—plays out differently for different patients. but the pressure points look familiar: unclear exceptions. fear of legal repercussions. and fewer clinicians willing to risk providing certain forms of care. In Thurman’s case. it took multiple ER visits before ectopic pregnancy was confirmed and treatment could proceed—after an OB-GYN had to intervene in person. In the broader data. those same forces show up as measurable shifts: more people waiting longer. and more care tilted away from medication regimens that clinicians describe as evidence-based.

For families facing pregnancy loss, the stakes are not abstract. They are measured in hours. in bleeding that doesn’t stop. in the moment a hospital door closes behind you with a diagnosis that turns out to be wrong. and in the time it takes before the right treatment finally reaches the body that needs it.

Dobbs Texas trigger ban abortion ban exceptions miscarriage care expectant management medication management mifepristone misoprostol ectopic pregnancy JAMA study maternal health